Syncronei Medical India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 15-05-2024
- Paid Up Capital ₹ 3.30 M
as on 15-05-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -61.15%
(FY 2020)
- Profit -65.86%
(FY 2020)
- Ebitda 111.65%
(FY 2020)
- Net Worth 2.98%
(FY 2020)
- Total Assets 7.34%
(FY 2020)
About Syncronei Medical India
The Company is engaged in the Events And Entertainment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.30 M, as per Ministry of Corporate Affairs (MCA) records.
Enti Reddy, Enti Jayareddy, and Soumya Reddy serve as directors at the Company.
- CIN/LLPIN
U33119KA2010PTC052067
- Company No.
052067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Syncronei Medical India Private Limited offer?
Syncronei Medical India Private Limited offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Dental Instruments, Scaffolding Pipes and Fittings, Scaffolding Accessories, Cardiac Drugs, Cholesterol Medicine, Forceps & Graspers, Surgical Staplers, Orthopedic Implants.
Who are the key members and board of directors at Syncronei Medical India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Enti Reddy  | Director | 04-Jan-2010 | Current |
| Enti Jayareddy | Director | 04-Jan-2010 | Current |
| Soumya Reddy | Director | 04-Jan-2014 | Current |
Financial Performance and Corporate Structure Insights of Syncronei Medical India.
Syncronei Medical India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 61.15% decrease. The company also saw a substantial fall in profitability, with a 65.86% decrease in profit. The company's net worth moved up by a moderate rise of 2.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syncronei Medical India?
In 2020, Syncronei Medical India had a promoter holding of 47.62% and a public holding of 52.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Legend Technologies (India) Private LimitedActive 26 years 7 monthsEnti Reddy and Enti Jayareddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syncronei Medical India?
Unlock and access historical data on people associated with Syncronei Medical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syncronei Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syncronei Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
